Username and password are case-sensitive.
ALL-SCT BFM International

Welcome to ALL-SCT BFM International

ALL-SCT BFM international is an open, multicentre, controlled, prospective study for therapy and therapy optimisation in patients with acute lymphoblastic leukaemia (ALL) and an indication for allogeneic hematopoietic stem cell transplantation (HSCT). The target group are children and adolescents less than 18 years old with the diagnosis ALL in first or any following remission with high risk of recurrence of their leukemia.
The main objectives are to evaluate whether HSCT from matched family or unrelated donors (MD) is equivalent to the HSCT from matched sibling donors (MSD) and to evaluate the efficacy of HSCT from mismatched family or unrelated donors (MMD) as compared to
AIT Austrian Institute of Technology, 2008. All rights reserved